38 Results for "

CAL

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "CAL" in MCE Product Catalog:

57
57 Publications Verification
Cat. No.: HY-13026
CAS No.: 870281-82-6
Purity:  99.69%
Synonyms: CAL-101; GS-1101
Target:  

PI3K Autophagy

Research Areas:  

Cancer

Idelalisib (CAL-101; GS-1101) is a highly selective and orally bioavailable p110δ inhibitor with an IC50 of 2.5 nM, showing 40- to 300-fold selectivity for p110δ over other PI3K class I enzymes.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12644
CAS No.: 870281-34-8
Purity:  99.98%
Synonyms: GS-9820; CAL-120
Target:  

PI3K

Research Areas:  

Cancer

Acalisib is a potent and selective PI3Kδ inhibitor with an IC50 of 12.7 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80889
Synonyms: S100A10; 42C; ANX2L; ANX2LG; CAL1L; CLP11; Ca[1]; GP11; P11; p10

Host:  

Mouse

Application:  

WB, ICC/IF, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P991558
Synonyms: RG-7356

Research Areas:  

Cancer

RO-5429083 (RG-7356) is a humanized monoclonal antibody targeting CD44. RO-5429083 binds to the extracellular domain of CD44 and inhibits constitutive EGFR phosphorylation. RO-5429083 suppresses tumor growth in xenograft models and can be used in research related to head and neck squamous cell carcinoma and acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-126536
CAS No.: 2378640-10-7
Purity:  98.82%
Target:  

Chemerin Receptor

Research Areas:  

Inflammation/Immunology

ChemR23-IN-1 (compound 2) is a ChemR23 inhibitor with IC50s of 38 nM and 100 nM for human and mouse ChemR23, respectively. ChemR23-IN-1 inhibits chemotaxis of CAL-1 triggered by Chemerin in vitro .
loading...
    loading...
Cat. No.: HY-123348
CAS No.: 129981-36-8
Purity:  99.22%
Synonyms: UK-81252
Sampatrilat (UK-81252) is a potent and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase (NEP). Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM). Sampatrilat (UK-81252) can be used for the study of chronic heart failure and blood pressure regulation .
loading...
    loading...
Cat. No.: HY-115753
CAS No.: 1448429-06-8
Target:  

Proteasome

Research Areas:  

Neurological Disease

Calpain Inhibitor-1 (compound 36) is a potent and selective cysteine protease calpain 1 (Cal1) inhibitor (IC50=100 nM; Ki=2.89 μM) .
loading...
    loading...
Cat. No.: HY-16122
CAS No.: 474012-90-3
Target:  

PI3K

Research Areas:  

Cancer

CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor.
loading...
    loading...
Cat. No.: HY-W704079
CAS No.: 22610-61-3
Synonyms: ​MG(18:0/0:0/0:0); L-(+)-1-Monostearin; 1-Octadecanoyl-sn-glycerol
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

1-Stearoyl-sn-glycerol is (MG(18:0/0:0/0:0); L-(+)-1-Monostearin; 1-Octadecanoyl-sn-glycerol) is a monoglyceride and also a metabolite found in plasma, which can be used in metabolomic analysis of plasma for coronary artery lesions (CAL) .
loading...
    loading...
Cat. No.: HY-12862
CAS No.: 1578244-34-4
Purity:  98.55%
Target:  

Mps1

Research Areas:  

Cancer

Mps1-IN-7 is a potent MPS1 inhibitor (IC50 of 0.020 μM) over JNK1 and JNK2 (JNK1 IC50= 0.11 μM, JNK2 IC50=0.22 μM). Mps1-IN-7 inhibit SW620, CAL51, Miapaca-2, RMG1 cell growth with GI50 values of 0.065, 0.068, 0.25, and 0.110 μM,respectively .
loading...
    loading...
Cat. No.: HY-16122A
CAS No.: 1431697-74-3
Target:  

PI3K

Research Areas:  

Cancer

CAL-130 is a PI3Kδ and PI3Kγ inhibitor with IC50s of 1.3 and 6.1 nM, respectively.
loading...
    loading...
Cat. No.: HY-162533
CAS No.: 3034764-32-1
Target:  

Molecular Glues

Research Areas:  

Cancer

GSPT1 degrader-4 (3) is a GSPT1 molecule glue (DC50 of 25.4 nM), with an IC50 of 39 nM for CAL51 proliferation .
loading...
    loading...
Cat. No.: HY-173064
Target:  

HDAC Parasite

Research Areas:  

Infection Cancer

DS-103 is an inhibitor for HDAC that inhibits HDAC1, HDAC2, HDAC3, HDAC6 and HDAC8 with IC50s of 0.029, 0.123, 0.022, 0.367 and 9.26 μM, respectively. DS-103 inhibits Plasmodium falciparum 3D7 with IC50 of 5.08 μM. DS-103 exhibits cytotoxicity in cells A2780 and Cal27 with IC50 of 1.48 μM and 1.47 μM, reverses Cisplatin (HY-17394) resistance in A2780 and Cal27 with IC50 of 4.62 μM and 2.23 μM. DS-103 exhibits synergistic effect with Cisplatin (HY-17394), enhances Cisplatin-induced apoptosis .
loading...
    loading...
Cat. No.: HY-P991498

Target:  

Influenza Virus

Research Areas:  

Infection

CAL-203 is a human monoclonal antibody (mAb) targeting F, Fusion glycoprotein F0. CAL-203 can be used in respiratory tract infections research.
loading...
    loading...
Cat. No.: HY-13026S
CAS No.: 1830330-31-8
Purity:  98.35%
Synonyms: CAL-101 d5; GS-1101 d5
Idelalisib-d5 is a deuterium labeled Idelalisib. Idelalisib is a highly selective and orally bioavailable p110δ inhibitor .
loading...
    loading...
Cat. No.: HY-16122B
CAS No.: 1431697-78-7
Target:  

PI3K

Research Areas:  

Cancer

CAL-130 is a PI3Kδ and PI3Kγ inhibitor with IC50s of 1.3 and 6.1 nM, respectively.
loading...
    loading...
Cat. No.: HY-P10806
CAS No.: 1364717-03-2
Target:  

CFTR

Research Areas:  

Endocrinology

kCAL01 is a CAL inhibitor with a Ki value of 2.3 μM. kCAL01 is promising for research of cystic fibrosis (CF) .
loading...
    loading...
Cat. No.: HY-13026R
CAS No.: 870281-82-6
Synonyms: CAL-101 (Standard); GS-1101 (Standard)
Research Areas:  

Cancer

Idelalisib (Standard) is the analytical standard of Idelalisib. This product is intended for research and analytical applications. Idelalisib (CAL-101; GS-1101) is a highly selective and orally bioavailable p110δ inhibitor with an IC50 of 2.5 nM, showing 40- to 300-fold selectivity for p110δ over other PI3K class I enzymes.
loading...
    loading...
Cat. No.: HY-RS04770
Research Areas:  

Others

FBLIM1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLIM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-157401
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC6-IN-29 (compound 11g), hydroxamic analogue, is a HDAC6 inhibitor. HDAC6-IN-29 has potent antiproliferative activity against CAL-51 cells (IC50 = 1.17 μM) and is able to induce apoptosis and cause accumulation of cells in the S phase of the cell cycle. HDAC6-IN-29 can be used for the research of cancer .
loading...
    loading...